
Philip Morris (PM) Stock Forecast & Price Target
Philip Morris (PM) Analyst Ratings
Bulls say
Philip Morris Intl is supported by a durable earnings engine that combines resilient combustible cash flow with accelerating smoke-free growth, allowing it to fund expansion without sacrificing financial strength. Strong recent execution showed 7.6% organic revenue growth, 10.4% reported revenue growth, and 13.6% LC EPS growth, while gross margin expansion and positive combustible volumes offset near-term pressure in U.S. ZYN. Its outlook is further reinforced by IQOS and ZYN leadership, MRTP authorization across 20 SKUs, and a prudent capital-allocation strategy that prioritizes reinvestment while maintaining a strong free cash flow profile and a top-tier dividend.
Bears say
Philip Morris Intl is facing a negative setup because its key growth engines may be losing momentum: IQOS could become a market share donor, U.S. nicotine pouch competition may slow revenue growth, and the PMTA process in the U.S. could face delays and regulatory hurdles. Declining combustible volumes and weaker pricing power would pressure revenue, gross margin, and earnings, while category weakness and market share erosion could weigh on the trading multiple. Even with estimated third quarter EPS of $2.23 and 4% organic revenue growth, the outlook remains fragile due to FX headwinds, margin constraints, and FDA compliance risk.
This aggregate rating is based on analysts' research of Philip Morris and is not a guaranteed prediction by Public.com or investment advice.
Philip Morris (PM) Analyst Forecast & Price Prediction
Start investing in Philip Morris (PM)
Order type
Buy in
Order amount
Est. shares
0 shares